PHASE-I TRIAL OF ISIS-2503, A 20-MER ANTISENSE PHOSPHOROTHIOATE OLIGONUCLEOTIDE AGAINST H-RAS, BY 14-DAY CONTINUOUS-INFUSION IN PATIENTS WITH ADVANCED CANCER

Authors
NEMUNAITIS J BRUCE J MONGIOVI D WEINBERGER K AZAD R MONIA B JOHNSTON J GEARY R KWOH J DORR A HOLMLUND J
Citation
J. Nemunaitis et al., PHASE-I TRIAL OF ISIS-2503, A 20-MER ANTISENSE PHOSPHOROTHIOATE OLIGONUCLEOTIDE AGAINST H-RAS, BY 14-DAY CONTINUOUS-INFUSION IN PATIENTS WITH ADVANCED CANCER, Annals of oncology, 9, 1998, pp. 324-324
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
2
Pages
324 - 324
Database
ISI
SICI code
0923-7534(1998)9:<324:PTOIA2>2.0.ZU;2-C